Literature DB >> 25393850

When should fQRS be evaluated as a noninvasive prognostic marker in patients undergoing primary PCI with STEMI?

Mehmet Gul1, Nevzat Uslu, Hulusi Satılmısoglu, Sinem Ozbay Ozyılmaz.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25393850      PMCID： PMC6931603          DOI： 10.1111/anec.12239

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


× No keyword cloud information.
  9 in total

1.  Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease.

Authors:  Mithilesh K Das; Bilal Khan; Sony Jacob; Awaneesh Kumar; Jo Mahenthiran
Journal:  Circulation       Date:  2006-05-22       Impact factor: 29.690

2.  Temporal trend might be better than instant occurrence of fQRS as a noninvasive prognostic marker in STEMI patients undergoing primary PCI.

Authors:  Uğur Canpolat; Dursun Aras; Serkan Topaloğlu; Sinan Aydoğdu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-11       Impact factor: 1.468

3.  Predictive value of a fragmented QRS complex in patients undergoing primary angioplasty for ST elevation myocardial infarction.

Authors:  Ozgur Akgul; Huseyin Uyarel; Hamdi Pusuroglu; Ozgur Surgit; Selahattin Turen; Mehmet Erturk; Erkan Ayhan; Umit Bulut; Omer Faruk Baycan; Ali Riza Demir; Nevzat Uslu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-07       Impact factor: 1.468

4.  The assessment of relationship between fragmented QRS complex and left ventricular wall motion score index in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention.

Authors:  Nevzat Uslu; Mehmet Gul; Huseyin Altug Cakmak; Ali Atam; Hamdi Pusuroglu; Hulusi Satilmisoglu; Emre Akkaya; Hale Unal Aksu; Ali Kemal Kalkan; Ozgur Surgit; Mehmet Erturk; Huseyin Aksu; Abdurrahman Eksik
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-07-17       Impact factor: 1.468

5.  Significance and usefulness of narrow fragmented QRS complex on 12-lead electrocardiogram in acute ST-segment elevation myocardial infarction for prediction of early mortality and morbidity.

Authors:  Berna Stavileci; Murat Cimci; Baris Ikitimur; Hasan Ali Barman; Sevgi Ozcan; Esra Ataoglu; Rasim Enar
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-02-12       Impact factor: 1.468

6.  Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction.

Authors:  Luc Lorgis; François Jourda; Olivier Hachet; Marianne Zeller; Aurelie Gudjoncik; Gilles Dentan; Karim Stamboul; Charles Guenancia; Laurent Mock; Yves Cottin
Journal:  Heart Lung       Date:  2013-07-11       Impact factor: 2.210

Review 7.  QRS fragmentation: diagnostic and prognostic significance.

Authors:  Grzegorz Pietrasik; Wojciech Zaręba
Journal:  Cardiol J       Date:  2012       Impact factor: 2.737

8.  Myocardial tissue perfusion predicts the evolution of fragmented QRS in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Firat Ozcan; Osman Turak; Uğur Canpolat; Iskender Kadife; Sedat Avci; Ahmet Işleyen; Muhammed Cebeci; Özgül Malçok Gürel; Fatma Nurcan Başar; Derya Tok; Serkan Topaloğlu; Dursun Aras; Sinan Aydoğdu
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-03-04       Impact factor: 1.468

9.  Usefulness of fragmented QRS on a 12-lead electrocardiogram in acute coronary syndrome for predicting mortality.

Authors:  Mithilesh K Das; Mark A Michael; Hussam Suradi; Jonathan Peng; Anjan Sinha; Changyu Shen; Jo Mahenthiran; Richard J Kovacs
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778
  9 in total
  1 in total

1.  The efficacy and safety of the short-term combination therapy with ticagrelor and PPIs or H2RA in patients with acute STEMI who underwent emergency PCI.

Authors:  Peng Wei; Shujiang Zhuo; Qiang Fu; Haibo Wang; Bin Zong; Bangming Cao; Liansheng Wang
Journal:  Clin Transl Sci       Date:  2021-10-20       Impact factor: 4.689
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.